NSEOutcome of Board Meeting6d ago · 12 Aug 2026, 06:15 pm
Outcome of Board Meeting
Natural Capsules Limited · NATCAPSUQ
✦ AI SummaryFundraise
Natural Capsules Limited has informed the Exchange regarding Outcome of Board Meeting held on August 12, 2026. The Board of Directors approved the Unaudited Consolidated & Standalone Financial Results for the Quarter ended June 30, 2026, and also approved the preferential issue of up to 1,25,000 equity shares and 5,00,000 convertible warrants to the promoter/promoter group at an issue price of ₹160 per equity share.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Natural Capsules Limited has informed the Exchange regarding Outcome of Board Meeting held on August 12, 2026.
Attachments (1)
📄pdf
Download →
NCL1993_12082026181451_Outcome_of_BM_and_Financial_Results_for_June_30_2026.pdf
View document text
cN flfl PI SU UH Lfl
' Q91 qu5
:2015
i0 r0 o1
e: n2 t0 a1 l5 )
Robt
), \)\ORSAE CA K &’A‘
L Management / Management /. brapers ACEREDITED o
CORP & REGD OFFICE : “ TRIDENT TOWERS” No. 23. 4th Floor, 100 feet Road. agar 2nd Block, Bangalore-560011
Phone : 080-26561562 / 1571 /1573 /581 URL : www.naturalcapsules.com Email : infot@naturalcapsules.com. CIN No. : L85 110KA1993PLCO14742
Date: August 12, 2026
To To
BSE Limited National Stock Exchange of India Limited
25th Floor, PJ Towers Exchange Plaza, C-1, Block G
Dalal Street, Bandra Kurla Complex, Bandra (E)
Mumbai — 400001 Mumbai — 400051
Scrip Code: 524654
Subject: Outcome of the Board Meeting held on Wednesday August 12, 2026.
This is to inform you that the Board of Directors at their meeting held on Wednesday August 12, 2026, have:
1. Approved the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter ended June 30,
2026.
2. Preferential issue of warrants:
a. The Preferential Issue of up to 1,25,000 ( One Lakh Twenty Five Thousand Only) Equity Shares of Face Value of
%10/- each ( Rupees Ten Only) to the person(s) belonging to the promoter /promoter group at an issue price of I160
(Rupees One Hundred Sixty Only) price determined as per the SEBI (Issue of Capital and Disclosure Requirements)
Regulation, 2018, subject to the approval of members in the General Meeting and other statutory and regulatory
approvals whereas necessary and applicable.
Further, the details as required under Regulation 30 of the Listing Regulations, 2015 read with SEBI Master Circular
HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated 30th January, 2026, is enclosed as Annexure A.
b. The issuance of 5,00,000 (Five Lakh only) Convertible Warrants each convertible into, 1 (one) fully paid-up equity
share of the Company of face value of I10/- each ( Rupees Ten Only) to the person(s) belonging to the
promoter/promoter group of the company, on a preferential basis (* Preferential Issue”) at an issue price of 160/~ (
Rupees One Hundred Sixty Only) price determined as per the SEBI (Issue of Capital and Disclosure Requirements)
Regulation, 2018, Minimum amount of I40/- (Rupees Fourty Only) which is equivalent to 25% of warrant Issue Price
shall be paid at the time of subscription and allotment of each warrant, Further subject to the approval of members in
the General Meeting and other statutory and regulatory approvals whereas necessary and applicable.
Further, the details as required under Regulation 30 of the Listing Regulations, 2015 read with SEBI Master Circular
HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated 30th January, 2026, is enclosed as Annexure A.
3. Considered and approved the draft Notice of Extra Ordinary General Meeting of the Members of the Company
scheduled to be held on Wednesday, 9" September, 2026, at the registered office of the company the relevant details will
be submitted to the Stock Exchange in due course of time.
4. The Board of Directors has appointed M/S Deepak Sadhu, Practicing Company Secretaries (COP: 14992), as the
Scrutinizer to the E-voting Process.
The Board Meeting commenced at 3:30 PM and concluded at 6:00 PM.
Kindly take the aforesaid information on record in compliance of SEBI (Listing Obligations and Disclosure Requirements),
Regulations 2015.
Yours Faithfully,
For Natural Capsules Limited
Akshay Dutta
Company Secretary and Compliance Officer
M.No. A80481
- 1: Plot No. 7A2, KIADB Industrial Area, Attibele-362 107, Bangalore. Tel : 08110-643068, Fax : 080-27820325
I1: R.S. No. 84, Perambai Road, Pitchaiveeranpet, Pondicherry - 605 010. Tel : 0413-2290833, Fax : 0413-2293251
NHTUHHL 150 150 e F\l)\OeSE N<
c fl P S U Le s Q9qu0a0l1ky :2015 e}n1v4i0r0o1nm e:n2t0a1l5 ] ey" +% -o
i Management// Management // Hiah &55fe F L %, &
e g gy
LIMITGD VG - Caps
CORP & REGD OFFICE : “ TRIDENT TOWERS” No. 23. 4th Floor, 100 feet Road. 2nd Block, Bangalore-560011
Phone : 080-26561562 / 1571 /1573 /581 URL : www.naturalcapsules.com Email : info@naturals capsules.com. CIN No. : LRSTT0KAT1993PLC0O14742
Annexure-A
The details as required to be disclosed under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Ci
rcular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026:
Sl | Particulars Remarks
1. Type of 1. Equity Shares of face value 310/- each
Securities
proposed to be 2. Warrants convertible into Equity Shares of face value 310/- each i.e. 1 Equity
issued (viz., Share per 1 Warrant.
equity shares,
convertibles etc.)
2. Type of Issuance | Preferential issuance under Chapter V of SEBI (Issue of Capital and Disclosure
Requirements) Regulations, 2018
3. Total number of 1. 1,25,000 Equity Shares at issue price of ¥160/- per Equity Share aggregating to
securities 2 crore to the persons belonging to Promoter/Promoter Group category.
proposed to be
issued or the 2. 5,00,000 Warrants, convertible into equivalent number of equity shares at an
total amount for issue price of I160/- per Equity Share (“Warrant Exercise Price”) aggregating to
which the 8 crore to the persons belonging to Promoter/Promoter Group category.
securities will be
issued
(approximately)
4. Additional details in case of preferential issue
4A. |Name of the 1. Mr. Sunil L Mundra (Promoter/Promoter Group) — 1,25.000 Equity Shares.
Investors -
EQUITY
4B. | Name of the 1. Mr. Sunil L Mundra (Promoter/Promoter Group) — 5.00,000 Warrants,
Investors - convertible into equivalent number of equity shares.
CONVERTIBLE
WARRANTS
4C. | Post allotment of || Particulars Pre-Preferential Allotment | *Post-Preferential Allotment
securities -
outcome of the No. of shares | %held No. of | %held
subscription, held shares held
issue price / Promoter/Promoter Group Category
allotted price (in || Mr. Sunil L |6.02.290 5.79% 12,27.290 11.12%
case of | | Mundra
convertibles), *Assuming full conversion of Warrants into equity shares
number of
investors. The post issue shareholding pattern has been prepared with shareholding as on 10th
August, 2026, on the basis that the proposed allottees would have subscribed to all the
warrants and have been allotted all the equity shares upon conversion of warrants.
%160/- per Equity Share price determined as per the SEBI (Issue of Capital and Disclosure
Requirements) Regulation, 2018
Unit - I : Plot No. 7A2, KIADB Industrial Area, Attibele-362 107, Bangalore. Tel : 08110-645068, Fa : 080-27820325
Unit- I1: R.S. No. 84, Perambai Road, Pitchaiveeranpet, Pondicherry - 605 010. Tel : 0413-2290833, Fax 1 0413-2293251
0SE Cap
150 150 e & AR
9001 :2015 )14001 :2015 | i
Qqualky environmental ey %
Management/ Management /) Hronaperers AC R 5 .
CORP& REGD OFFICE “ TRIDENT TOWERS” No. 23. 4th Floor, 100 et Road. 2nd Block, Bangalore-560011
Phone : 08! 0-26561562/ 1571 /1573 /581 URL : www.naturalcapsules.com Email : info(@natural om, CIN No. : LRS1T0KA1993PLCO14742
4D. |Issue Price — | I160/- ( Rupees One Hundred Sixty Only) Price determined as per the SEBI (Issue of
Equity & | Capital and Disclosure Requirements) Regulations, 2018
Convertibles
‘Warrants
4E. |In case of | Each Warrant would be convertible into one equity share and the rights attached to the
convertibles - | Warrants can be exercised at any time within a period of 18 (Eighteen) months from the
intimation on | date of allotment of Warrants.
conversion of | An amount equivalent to 25% of the Warrant Exercise Price shall be payable at the time
securities or on | of subscription and allotment of each Warrant and the balance 75% of the Warrant
lapse of the | Exercise Price shall be payable by the Warrant holder against each Warrant at the time of
tenure of the | allotment of Equity Shares pursuant to exercise of the options attached to Warrant(s) to
instrument subscribe to the Equity Share(s). The amount paid against Warrants shall be adjusted/
set-off against the issue price for the resultant Equity Shares.
In case the Warrant holder fails to exercise the Warrant within a period of 18 months
from date of allotment of Warrant, the
[Showing first 8,000 characters — download PDF for full document]